MarDee Haring-Layton - 12 Mar 2024 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DARE	Employee Stock Option (right to buy)	Award	$0	+290,000		$0.000000	290,000	12 Mar 2024	Common stock	290,000	$0.4600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.